173 related articles for article (PubMed ID: 19463000)
1. High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.
Baqi Y; Atzler K; Köse M; Glänzel M; Müller CE
J Med Chem; 2009 Jun; 52(12):3784-93. PubMed ID: 19463000
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y2 receptor antagonists.
Weyler S; Baqi Y; Hillmann P; Kaulich M; Hunder AM; Müller IA; Müller CE
Bioorg Med Chem Lett; 2008 Jan; 18(1):223-7. PubMed ID: 18006312
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and preliminary evaluation of [3H]PSB-0413, a selective antagonist radioligand for platelet P2Y12 receptors.
El-Tayeb A; Griessmeier KJ; Müller CE
Bioorg Med Chem Lett; 2005 Dec; 15(24):5450-2. PubMed ID: 16213725
[TBL] [Abstract][Full Text] [Related]
4. Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.
Baqi Y; Lee SY; Iqbal J; Ripphausen P; Lehr A; Scheiff AB; Zimmermann H; Bajorath J; Müller CE
J Med Chem; 2010 Mar; 53(5):2076-86. PubMed ID: 20146483
[TBL] [Abstract][Full Text] [Related]
5. Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.
Baqi Y; Hausmann R; Rosefort C; Rettinger J; Schmalzing G; Müller CE
J Med Chem; 2011 Feb; 54(3):817-30. PubMed ID: 21207957
[TBL] [Abstract][Full Text] [Related]
6. Interaction of new, very potent non-nucleotide antagonists with Arg256 of the human platelet P2Y12 receptor.
Hoffmann K; Baqi Y; Morena MS; Glänzel M; Müller CE; von Kügelgen I
J Pharmacol Exp Ther; 2009 Nov; 331(2):648-55. PubMed ID: 19690189
[TBL] [Abstract][Full Text] [Related]
7. 6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors.
Crepaldi P; Cacciari B; Bonache MC; Spalluto G; Varani K; Borea PA; Kügelgen Iv; Hoffmann K; Pugliano M; Razzari C; Cattaneo M
Bioorg Med Chem; 2009 Jul; 17(13):4612-21. PubMed ID: 19464902
[TBL] [Abstract][Full Text] [Related]
8. Development of Potent and Selective Antagonists for the UTP-Activated P2Y
Rafehi M; Malik EM; Neumann A; Abdelrahman A; Hanck T; Namasivayam V; Müller CE; Baqi Y
J Med Chem; 2017 Apr; 60(7):3020-3038. PubMed ID: 28306255
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of 2-alkylated deoxyadenosine bisphosphate derivatives as P2Y(1) receptor antagonists.
Mathieu R; Baurand A; Schmitt M; Gachet C; Bourguignon JJ
Bioorg Med Chem; 2004 Apr; 12(7):1769-79. PubMed ID: 15028267
[TBL] [Abstract][Full Text] [Related]
10. Convergent synthesis of the potent P2Y receptor antagonist MG 50-3-1 based on a regioselective Ullmann coupling reaction.
Baqi Y; Müller CE
Molecules; 2012 Mar; 17(3):2599-615. PubMed ID: 22391596
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of alkyl- and aryl-amino-substituted anthraquinone derivatives by microwave-assisted copper(0)-catalyzed Ullmann coupling reactions.
Baqi Y; Müller CE
Nat Protoc; 2010 May; 5(5):945-53. PubMed ID: 20431540
[TBL] [Abstract][Full Text] [Related]
12. Rapid and efficient microwave-assisted copper(0)-catalyzed ullmann coupling reaction: general access to anilinoanthraquinone derivatives.
Baqi Y; Müller CE
Org Lett; 2007 Mar; 9(7):1271-4. PubMed ID: 17348665
[TBL] [Abstract][Full Text] [Related]
13. Adenosine analogues as inhibitors of P2Y12 receptor mediated platelet aggregation.
Douglass JG; deCamp JB; Fulcher EH; Jones W; Mahanty S; Morgan A; Smirnov D; Boyer JL; Watson PS
Bioorg Med Chem Lett; 2008 Mar; 18(6):2167-71. PubMed ID: 18276138
[TBL] [Abstract][Full Text] [Related]
14. Tetrahydro-4-quinolinamines identified as novel P2Y(1) receptor antagonists.
Morales-Ramos AI; Mecom JS; Kiesow TJ; Graybill TL; Brown GD; Aiyar NV; Davenport EA; Kallal LA; Knapp-Reed BA; Li P; Londregan AT; Morrow DM; Senadhi S; Thalji RK; Zhao S; Burns-Kurtis CL; Marino JP
Bioorg Med Chem Lett; 2008 Dec; 18(23):6222-6. PubMed ID: 18926700
[TBL] [Abstract][Full Text] [Related]
15. Development of Anthraquinone Derivatives as Ectonucleoside Triphosphate Diphosphohydrolase (NTPDase) Inhibitors With Selectivity for NTPDase2 and NTPDase3.
Baqi Y; Rashed M; Schäkel L; Malik EM; Pelletier J; Sévigny J; Fiene A; Müller CE
Front Pharmacol; 2020; 11():1282. PubMed ID: 32973513
[TBL] [Abstract][Full Text] [Related]
16. P2Y1 receptor antagonists as novel antithrombotic agents.
Pfefferkorn JA; Choi C; Winters T; Kennedy R; Chi L; Perrin LA; Lu G; Ping YW; McClanahan T; Schroeder R; Leininger MT; Geyer A; Schefzick S; Atherton J
Bioorg Med Chem Lett; 2008 Jun; 18(11):3338-43. PubMed ID: 18445527
[TBL] [Abstract][Full Text] [Related]
17. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists.
Kim HS; Ohno M; Xu B; Kim HO; Choi Y; Ji XD; Maddileti S; Marquez VE; Harden TK; Jacobson KA
J Med Chem; 2003 Nov; 46(23):4974-87. PubMed ID: 14584948
[TBL] [Abstract][Full Text] [Related]
18. Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.
Parlow JJ; Burney MW; Case BL; Girard TJ; Hall KA; Hiebsch RR; Huff RM; Lachance RM; Mischke DA; Rapp SR; Woerndle RS; Ennis MD
Bioorg Med Chem Lett; 2009 Aug; 19(16):4657-63. PubMed ID: 19604694
[TBL] [Abstract][Full Text] [Related]
19. Involvement of basic amino acid residues in transmembrane regions 6 and 7 in agonist and antagonist recognition of the human platelet P2Y(12)-receptor.
Hoffmann K; Sixel U; Di Pasquale F; von Kügelgen I
Biochem Pharmacol; 2008 Nov; 76(10):1201-13. PubMed ID: 18809389
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship of quinoline derivatives as potent and selective alpha(2C)-adrenoceptor antagonists.
Höglund IP; Silver S; Engström MT; Salo H; Tauber A; Kyyrönen HK; Saarenketo P; Hoffrén AM; Kokko K; Pohjanoksa K; Sallinen J; Savola JM; Wurster S; Kallatsa OA
J Med Chem; 2006 Oct; 49(21):6351-63. PubMed ID: 17034141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
